257: Lilly's Alzheimer's success, a milestone FDA approval, & Moderna's shrinking business
The Readout Loud
00:00
The 60 Year Quest to Develop an RSV Vaccine
K's RSV vaccine for older adults ages 60 plus was approved by the FDA this week. We're at the beginning of what's expected to be sort of a long series of RSV vaccines coming to market. And we will now actually discuss the phase three data from Denanimab and Alzheimer's disease treatment from Eli Lilly.
Transcript
Play full episode
